StockWatch
·
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Corporate ActionJun 29, 2026, 03:57 PM

Trinity Biotech Terminates Equity Purchase Agreement with Yorkville

AI Summary

Trinity Biotech PLC announced the termination of its Standby Equity Purchase Agreement with YA II PN, LTD., an affiliate of Yorkville Advisors Global. The company delivered notice of this termination on June 29, 2026. This action impacts the company's equity financing arrangements.

Key Highlights

  • Trinity Biotech terminated its Standby Equity Purchase Agreement.
  • The agreement was with YA II PN, LTD., an affiliate of Yorkville Advisors Global.
  • Notice of termination was delivered on June 29, 2026.